These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 18708356)

  • 21. Positively charged amino acids flanking a sumoylation consensus tetramer on the 110kDa tri-snRNP component SART1 enhance sumoylation efficiency.
    Schimmel J; Balog CI; Deelder AM; Drijfhout JW; Hensbergen PJ; Vertegaal AC
    J Proteomics; 2010 Jun; 73(8):1523-34. PubMed ID: 20346425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition.
    Gareau JR; Lima CD
    Nat Rev Mol Cell Biol; 2010 Dec; 11(12):861-71. PubMed ID: 21102611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polymeric chains of SUMO-2 and SUMO-3 are conjugated to protein substrates by SAE1/SAE2 and Ubc9.
    Tatham MH; Jaffray E; Vaughan OA; Desterro JM; Botting CH; Naismith JH; Hay RT
    J Biol Chem; 2001 Sep; 276(38):35368-74. PubMed ID: 11451954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-native Conformers of Cystic Fibrosis Transmembrane Conductance Regulator NBD1 Are Recognized by Hsp27 and Conjugated to SUMO-2 for Degradation.
    Gong X; Ahner A; Roldan A; Lukacs GL; Thibodeau PH; Frizzell RA
    J Biol Chem; 2016 Jan; 291(4):2004-2017. PubMed ID: 26627832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The N-terminal internal region of BLM is required for the formation of dots/rod-like structures which are associated with SUMO-1.
    Suzuki H; Seki M; Kobayashi T; Kawabe Yi ; Kaneko H; Kondo N; Harata M; Mizuno S; Masuko T; Enomoto T
    Biochem Biophys Res Commun; 2001 Aug; 286(2):322-7. PubMed ID: 11500040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systematic identification and analysis of mammalian small ubiquitin-like modifier substrates.
    Gocke CB; Yu H; Kang J
    J Biol Chem; 2005 Feb; 280(6):5004-12. PubMed ID: 15561718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural attributes in the conjugation of ubiquitin, SUMO and RUB to protein substrates.
    Goettsch S; Bayer P
    Front Biosci; 2002 Aug; 7():a148-62. PubMed ID: 12133807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modification of papillomavirus E2 proteins by the small ubiquitin-like modifier family members (SUMOs).
    Wu YC; Roark AA; Bian XL; Wilson VG
    Virology; 2008 Sep; 378(2):329-38. PubMed ID: 18619639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distinct and overlapping sets of SUMO-1 and SUMO-2 target proteins revealed by quantitative proteomics.
    Vertegaal AC; Andersen JS; Ogg SC; Hay RT; Mann M; Lamond AI
    Mol Cell Proteomics; 2006 Dec; 5(12):2298-310. PubMed ID: 17000644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and Characterization of SUMO-SIM Interactions.
    Husnjak K; Keiten-Schmitz J; Müller S
    Methods Mol Biol; 2016; 1475():79-98. PubMed ID: 27631799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fourier transform ion cyclotron resonance mass spectrometry for the analysis of small ubiquitin-like modifier (SUMO) modification: identification of lysines in RanBP2 and SUMO targeted for modification during the E3 autoSUMOylation reaction.
    Cooper HJ; Tatham MH; Jaffray E; Heath JK; Lam TT; Marshall AG; Hay RT
    Anal Chem; 2005 Oct; 77(19):6310-9. PubMed ID: 16194093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Small Ubiquitin-like Modifier Alters IFN Response.
    Maarifi G; Maroui MA; Dutrieux J; Dianoux L; Nisole S; Chelbi-Alix MK
    J Immunol; 2015 Sep; 195(5):2312-24. PubMed ID: 26223657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The CTCF insulator protein is posttranslationally modified by SUMO.
    MacPherson MJ; Beatty LG; Zhou W; Du M; Sadowski PD
    Mol Cell Biol; 2009 Feb; 29(3):714-25. PubMed ID: 19029252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modification of cardiac transcription factor Gata6 by SUMO.
    Chen H; Sun W; Zhu J; Yuan H; Chu M; Wen B
    Biochimie; 2020 Mar; 170():212-218. PubMed ID: 32017966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro modification of human centromere protein CENP-C fragments by small ubiquitin-like modifier (SUMO) protein: definitive identification of the modification sites by tandem mass spectrometry analysis of the isopeptides.
    Chung TL; Hsiao HH; Yeh YY; Shia HL; Chen YL; Liang PH; Wang AH; Khoo KH; Shoei-Lung Li S
    J Biol Chem; 2004 Sep; 279(38):39653-62. PubMed ID: 15272016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intra-nuclear trafficking of the BLM helicase to DNA damage-induced foci is regulated by SUMO modification.
    Eladad S; Ye TZ; Hu P; Leversha M; Beresten S; Matunis MJ; Ellis NA
    Hum Mol Genet; 2005 May; 14(10):1351-65. PubMed ID: 15829507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of protein SUMOylation sites by mass spectrometry using combined microwave-assisted aspartic acid cleavage and tryptic digestion.
    Osula O; Swatkoski S; Cotter RJ
    J Mass Spectrom; 2012 May; 47(5):644-54. PubMed ID: 22576878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanism and consequences for paralog-specific sumoylation of ubiquitin-specific protease 25.
    Meulmeester E; Kunze M; Hsiao HH; Urlaub H; Melchior F
    Mol Cell; 2008 Jun; 30(5):610-9. PubMed ID: 18538659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Covalent modification of the homeodomain-interacting protein kinase 2 (HIPK2) by the ubiquitin-like protein SUMO-1.
    Kim YH; Choi CY; Kim Y
    Proc Natl Acad Sci U S A; 1999 Oct; 96(22):12350-5. PubMed ID: 10535925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted identification of SUMOylation sites in human proteins using affinity enrichment and paralog-specific reporter ions.
    Lamoliatte F; Bonneil E; Durette C; Caron-Lizotte O; Wildemann D; Zerweck J; Wenshuk H; Thibault P
    Mol Cell Proteomics; 2013 Sep; 12(9):2536-50. PubMed ID: 23750026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.